Morgan Stanley's first quarter 2026 earnings, covering January through March, come at a time when Wall Street is seeing renewed activity from recovering dealmaking and market volatility. As one of the top global financial services firms, these results highlight its position across investment banking, trading, and wealth management—core areas that drive revenue in today's high-interest-rate landscape. From what I see, investors are paying close attention to these numbers for insights into trading volumes, M&A activity, and client flows, particularly after strong reports from peers like JPMorgan and Goldman Sachs. A solid showing here reinforces MS's pivot toward the stability of wealth management while taking advantage of the capital markets rebound, which could shape the stock's valuation and broader sector outlook.
Morgan Stanley delivered impressive first quarter 2026 results, with net revenues reaching a record $20.6 billion—a 16% rise from $17.7 billion a year earlier and surpassing the $19.72 billion consensus. Diluted EPS landed at $3.43, beating estimates of $3.00 to $3.09 and improving from $2.60 last year, as net income climbed 29% to $5.57 billion.
In Institutional Securities, fixed income revenue increased 29% to $3.36 billion, equity trading hit a record $5.15 billion (up 25%), and investment banking revenues jumped 36% to $2.12 billion, driven by advisory strength. Wealth Management showed steady client asset growth beyond $9 trillion, bolstered by solid net new assets and fee income for stability. Investment Management added consistent contributions. ROTCE stood at a strong 27.1%. The firm offered no specific quarterly guidance but highlighted ongoing share repurchases totaling $1.75 billion. I also checked these figures against industry peers using Tickeron’s AI Screener, which confirmed the standout performance in trading.
After the April 15 release, MS shares climbed around 4-5% in pre-market and after-hours trading, underscoring investor approval of the strong results and record figures. Sentiment has shifted bullish, with analysts pointing to the across-the-board beats in trading and advisory as proof of the firm's edge in volatile markets. That said, a few voices note the risk of stretched valuations after the rally.
In my research workflow, Tickeron’s AI Screener stands out as a powerful way to scan stocks and ETFs using technical patterns, fundamentals, trends, volatility, and AI signals. It lets me filter thousands of names by industry, market cap, indicators, price patterns, and performance metrics to uncover trade ideas, breakouts, and opportunities faster than manual methods. I’ve found it especially useful for contextualizing results like these in the financial sector.
One area I’m watching closely is Morgan Stanley's wealth management trajectory, where client assets topped $9 trillion with strong net new flows—this segment's stability could buffer against capital markets ups and downs.
In Institutional Securities, the dealmaking pipeline will be pivotal. The rise in M&A and equity underwriting fees points to optimism, though geopolitical risks and interest rate developments bear monitoring. Trading benefited from volatility in commodities and equities; ongoing dislocations could sustain revenues, but normalization might pressure them.
On the macro side, keep an eye on regulatory pressures around capital rules and expense control. The firm expects a 2026 effective tax rate of 22-23%, with quarterly variability. Near-term catalysts include Q2 trading volumes, wealth lending trends, and buyback updates. Management's comments on high asset prices and narrow credit spreads call for caution.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Be on the lookout for a price bounce soon.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in of 355 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 306 cases where MS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for MS moved out of overbought territory on June 24, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on June 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MS as a result. In of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for MS turned negative on June 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MS broke above its upper Bollinger Band on June 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.427) is normal, around the industry mean (4.088). P/E Ratio (20.570) is within average values for comparable stocks, (48.334). Projected Growth (PEG Ratio) (2.730) is also within normal values, averaging (1.857). Dividend Yield (0.018) settles around the average of (0.035) among similar stocks. P/S Ratio (5.238) is also within normal values, averaging (32.214).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of diversified financial services including brokerage, investment management and venture capital services
Industry InvestmentBanksBrokers